{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:28:32Z","timestamp":1768771712094,"version":"3.49.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.expneurol.2022.114170","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T21:56:56Z","timestamp":1658181416000},"page":"114170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome"],"prefix":"10.1016","volume":"357","author":[{"given":"Nicole K.","family":"Morrill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelie","family":"Joly-Amado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyou","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahana","family":"Prabhudeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin J.","family":"Weeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin R.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2022.114170_bb0005","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/jcp.25605","article-title":"Interfering of the Reelin\/ApoER2\/PSD95 signaling Axis reactivates Dendritogenesis of mature hippocampal neurons","volume":"232","author":"Ampuero","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000072845","article-title":"Understanding fragile X syndrome: insights from animal models","volume":"100","author":"Bakker","year":"2003","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.expneurol.2022.114170_bb0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1866-1955-6-25","article-title":"Mouse models of the fragile X premutation and fragile X-associated tremor\/ataxia syndrome","volume":"6","author":"Berman","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.expneurol.2022.114170_bb0025","doi-asserted-by":"crossref","first-page":"152ra127","DOI":"10.1126\/scitranslmed.3004214","article-title":"Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial","volume":"4","author":"Berry-Kravis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2022.114170_bb0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.nbd.2009.12.006","article-title":"Beta-amyloid controls altered Reelin expression and processing in Alzheimer\u2019s disease","volume":"37","author":"Botella-Lopez","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2022.114170_bb0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0092-8674(01)00568-2","article-title":"Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome","volume":"107","author":"Brown","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2022.114170_bb0040","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nm.3127","article-title":"Targeting the endocannabinoid system in the treatment of fragile X syndrome","volume":"19","author":"Busquets-Garcia","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2022.114170_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094037","article-title":"PSD95 suppresses dendritic arbor development in mature hippocampal neurons by occluding the clustering of NR2B-NMDA receptors","volume":"9","author":"Bustos","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2022.114170_bb0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jneumeth.2010.10.010","article-title":"Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain","volume":"194","author":"Carty","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2022.114170_bb0055","doi-asserted-by":"crossref","first-page":"eaau9859","DOI":"10.1126\/sciadv.aau9859","article-title":"Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion","volume":"4","author":"Castle","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.expneurol.2022.114170_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuro.2017.01.005","article-title":"Risk factors for the onset and progression of Huntington disease","volume":"61","author":"Chao","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2022.114170_bb0065","doi-asserted-by":"crossref","first-page":"10164","DOI":"10.1523\/JNEUROSCI.2379-06.2006","article-title":"Activity-independent regulation of dendrite patterning by postsynaptic density protein PSD-95","volume":"26","author":"Charych","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0070","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(03)00406-8","article-title":"The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences","volume":"120","author":"Chen","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2022.114170_bb0075","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/hmg\/ddg331","article-title":"The (CGG)n repeat element within the 5\u2032 untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter","volume":"12","author":"Chen","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2022.114170_bb0080","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1523\/JNEUROSCI.1951-05.2005","article-title":"Reelin modulates NMDA receptor activity in cortical neurons","volume":"25","author":"Chen","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0085","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1523\/JNEUROSCI.3758-06.2007","article-title":"Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer\u2019s disease","volume":"27","author":"Chin","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0090","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00125817-200109000-00006","article-title":"FMR1 and the fragile X syndrome: human genome epidemiology review","volume":"3","author":"Crawford","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.expneurol.2022.114170_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajmg.1320380221","article-title":"Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features","volume":"38","author":"Cronister","year":"1991","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.expneurol.2022.114170_bb0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/374719a0","article-title":"A protein related to extracellular matrix proteins deleted in the mouse mutant reeler","volume":"374","author":"D'Arcangelo","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2022.114170_bb0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0896-6273(00)80860-0","article-title":"Reelin is a ligand for lipoprotein receptors","volume":"24","author":"D'Arcangelo","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2022.114170_bb0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbr.2014.05.046","article-title":"Behavioral analysis of male and female Fmr1 knockout mice on C57BL\/6 background","volume":"271","author":"Ding","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2022.114170_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cge.13039","article-title":"Metformin as targeted treatment in fragile X syndrome","volume":"93","author":"Dy","year":"2018","journal-title":"Clin. Genet."},{"key":"10.1016\/j.expneurol.2022.114170_bb0120","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1073\/pnas.0609307104","article-title":"PSD-95 is required for activity-driven synapse stabilization","volume":"104","author":"Ehrlich","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2022.114170_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1083\/jcb.148.1.159","article-title":"Dual palmitoylation of PSD-95 mediates its vesiculotubular sorting, postsynaptic targeting, and ion channel clustering","volume":"148","author":"El-Husseini","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0130","doi-asserted-by":"crossref","first-page":"20953","DOI":"10.1073\/pnas.0811025106","article-title":"Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development","volume":"105","author":"Elias","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2022.114170_bb0135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jpsychires.2014.07.011","article-title":"Impact of acamprosate on plasma amyloid-beta precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker","volume":"59","author":"Erickson","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.expneurol.2022.114170_bb0140","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1097\/00001756-200110290-00014","article-title":"Altered levels of Reelin and its isoforms in schizophrenia and mood disorders","volume":"12","author":"Fatemi","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2022.114170_bb0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2012.08.015","article-title":"The involvement of Reelin in neurodevelopmental disorders","volume":"68","author":"Folsom","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2022.114170_bb0150","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0092-8674(91)90283-5","article-title":"Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox","volume":"67","author":"Fu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2022.114170_bb0155","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ejhg.2008.61","article-title":"Fragile X syndrome","volume":"16","author":"Garber","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2022.114170_bb0160","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/aur.1814","article-title":"Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: the relevance of early life phases","volume":"10","author":"Gaudissard","year":"2017","journal-title":"Autism Res."},{"key":"10.1016\/j.expneurol.2022.114170_bb0165","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/DBP.0000000000000334","article-title":"A randomized, double-blind, placebo-controlled trial of low-dose sertraline in young children with fragile X syndrome","volume":"37","author":"Greiss Hess","year":"2016","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.expneurol.2022.114170_bb0170","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/13854046.2016.1184652","article-title":"The fragile X mental retardation 1 gene (FMR1): historical perspective, phenotypes, mechanism, pathology, and epidemiology","volume":"30","author":"Grigsby","year":"2016","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jns.2006.05.016","article-title":"Impairment in the cognitive functioning of men with fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"248","author":"Grigsby","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/mds.21359","article-title":"Impairment of executive cognitive functioning in males with fragile X-associated tremor\/ataxia syndrome","volume":"22","author":"Grigsby","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2022.114170_bb0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2006.02.044","article-title":"Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines","volume":"1084","author":"Grossman","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2022.114170_bb0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2010.07.090","article-title":"Developmental characteristics of dendritic spines in the dentate gyrus of Fmr1 knockout mice","volume":"1355","author":"Grossman","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2022.114170_bb0195","doi-asserted-by":"crossref","first-page":"14653","DOI":"10.1038\/s41598-017-15028-x","article-title":"Multiple behavior phenotypes of the fragile-X syndrome mouse model respond to chronic inhibition of phosphodiesterase-4D (PDE4D)","volume":"7","author":"Gurney","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2022.114170_bb0200","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/jmg.2008.059055","article-title":"The fragile X prevalence paradox","volume":"45","author":"Hagerman","year":"2008","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.expneurol.2022.114170_bb0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mcn.2013.07.012","article-title":"Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons","volume":"57","author":"Henriquez","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0210","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/ejn.12893","article-title":"Reelin supplementation recovers synaptic plasticity and cognitive deficits in a mouse model for Angelman syndrome","volume":"41","author":"Hethorn","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11689-019-9277-x","article-title":"A phase 1\/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome","volume":"11","author":"Heussler","year":"2019","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.expneurol.2022.114170_bb0220","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0896-6273(00)80861-2","article-title":"Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation","volume":"24","author":"Hiesberger","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2022.114170_bb0225","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1073\/pnas.122205699","article-title":"Altered synaptic plasticity in a mouse model of fragile X mental retardation","volume":"99","author":"Huber","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2022.114170_bb0230","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","article-title":"Therapeutic AAV gene transfer to the nervous system: a clinical reality","volume":"101","author":"Hudry","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2022.114170_bb0235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2009.09.120","article-title":"Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders","volume":"1309","author":"Hutsler","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2022.114170_bb0240","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fncel.2020.00285","article-title":"Reelin supplementation into the Hippocampus rescues abnormal behavior in a mouse model of neurodevelopmental disorders","volume":"14","author":"Ibi","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0245","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.nbd.2003.11.008","article-title":"Characterization of the various forms of the Reelin protein in the cerebrospinal fluid of normal subjects and in neurological diseases","volume":"15","author":"Ignatova","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2022.114170_bb0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B","article-title":"Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination","volume":"98","author":"Irwin","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.expneurol.2022.114170_bb0255","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1128\/MCB.00928-07","article-title":"Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth","volume":"27","author":"Jossin","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0260","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1523\/JNEUROSCI.3408-03.2004","article-title":"The central fragment of Reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development","volume":"24","author":"Jossin","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104722","article-title":"Translational validity and methodological underreporting in animal research: a systematic review and meta-analysis of the fragile X syndrome (Fmr1 KO) rodent model","volume":"139","author":"Kat","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2022.114170_bb0270","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5582\/irdr.2014.01024","article-title":"Modeling fragile X syndrome in the Fmr1 knockout mouse","volume":"3","author":"Kazdoba","year":"2014","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.expneurol.2022.114170_bb0275","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ajmg.1320300118","article-title":"Cognitive profiles of boys with the fragile X syndrome","volume":"30","author":"Kemper","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.expneurol.2022.114170_bb0280","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1139\/o99-035","article-title":"Biology of the fragile X mental retardation protein, an RNA-binding protein","volume":"77","author":"Khandjian","year":"1999","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2015.05.033","article-title":"Extracellular matrix protein reelin regulate dendritic spine density through CaMKIIbeta","volume":"599","author":"Kim","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2022.114170_bb0290","doi-asserted-by":"crossref","first-page":"12922","DOI":"10.1074\/jbc.M113.536326","article-title":"Cleavage within Reelin repeat 3 regulates the duration and range of the signaling activity of Reelin protein","volume":"289","author":"Koie","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2022.114170_bb0295","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/exnr.1998.7007","article-title":"Reelin, the extracellular matrix protein deficient in reeler mutant mice, is processed by a metalloproteinase","volume":"156","author":"Lambert de Rouvroit","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0300","doi-asserted-by":"crossref","first-page":"20307","DOI":"10.1074\/jbc.M114.576249","article-title":"Reelin induces Erk1\/2 signaling in cortical neurons through a non-canonical pathway","volume":"289","author":"Lee","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2022.114170_bb0305","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/DBP.0b013e318287cd17","article-title":"A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome","volume":"34","author":"Leigh","year":"2013","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.expneurol.2022.114170_bb0310","article-title":"Central Repeat Fragment of Reelin is Sufficient to Evoke Receptor Clustering and Intracellular Signaling","author":"Li","year":"2022","journal-title":"Molecular Cell Res."},{"key":"10.1016\/j.expneurol.2022.114170_bb0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11689-017-9207-8","article-title":"A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome","volume":"9","author":"Ligsay","year":"2017","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.expneurol.2022.114170_bb0320","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1113\/jphysiol.2002.034918","article-title":"PSD-95 regulates NMDA receptors in developing cerebellar granule neurons of the rat","volume":"548","author":"Losi","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0325","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2014.210","article-title":"Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates","volume":"23","author":"Meyer","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2022.114170_bb0330","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0896-6273(03)00034-5","article-title":"RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice","volume":"37","author":"Miyashiro","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2022.114170_bb0335","doi-asserted-by":"crossref","first-page":"15537","DOI":"10.1073\/pnas.0707484104","article-title":"Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors","volume":"104","author":"Nakamoto","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2022.114170_bb0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0896-6273(03)00819-5","article-title":"Reelin promotes hippocampal dendrite development through the VLDLR\/ApoER2-Dab1 pathway","volume":"41","author":"Niu","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2022.114170_bb0345","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.1523\/JNEUROSCI.1917-08.2008","article-title":"The Reelin signaling pathway promotes dendritic spine development in hippocampal neurons","volume":"28","author":"Niu","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0350","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/0883073817712875","article-title":"Autism symptoms in fragile X syndrome","volume":"32","author":"Niu","year":"2017","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0355","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1038\/s41598-020-61380-w","article-title":"Physiological significance of proteolytic processing of Reelin revealed by cleavage-resistant Reelin knock-in mice","volume":"10","author":"Okugawa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2022.114170_bb0360","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2377-10-91","article-title":"Open-label add-on treatment trial of minocycline in fragile X syndrome","volume":"10","author":"Paribello","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0365","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2022.114170_bb0370","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1523\/JNEUROSCI.5284-09.2010","article-title":"Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation","volume":"30","author":"Pujadas","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0375","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1152\/jn.00869.2006","article-title":"Reelin signaling facilitates maturation of CA1 glutamatergic synapses","volume":"97","author":"Qiu","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0380","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.nlm.2005.11.001","article-title":"Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice","volume":"85","author":"Qiu","year":"2006","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.expneurol.2022.114170_bb0385","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamapsychiatry.2016.0838","article-title":"Efficacy and safety of basimglurant as adjunctive therapy for major depression: a randomized clinical trial","volume":"73","author":"Quiroz","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.expneurol.2022.114170_bb0390","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1352\/1944-7558-115.6.482","article-title":"Obesity, food selectivity, and physical activity in individuals with fragile X syndrome","volume":"115","author":"Raspa","year":"2010","journal-title":"Am. J. Intellect. Dev. Disab."},{"key":"10.1016\/j.expneurol.2022.114170_bb0395","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1101\/lm.2153511","article-title":"Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density","volume":"18","author":"Rogers","year":"2011","journal-title":"Learn. Mem."},{"key":"10.1016\/j.expneurol.2022.114170_bb0400","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/0269881112463468","article-title":"Reelin supplementation recovers sensorimotor gating, synaptic plasticity and associative learning deficits in the heterozygous reeler mouse","volume":"27","author":"Rogers","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.expneurol.2022.114170_bb0405","doi-asserted-by":"crossref","first-page":"190","DOI":"10.25100\/cm.v45i4.1810","article-title":"Fragile X syndrome","volume":"45","author":"Saldarriaga","year":"2014","journal-title":"Colomb. Med. (Calif.)"},{"key":"10.1016\/j.expneurol.2022.114170_bb0410","first-page":"305","article-title":"Determination of cleavage site of Reelin between its sixth and seventh repeat and contribution of meprin metalloproteases to the cleavage","volume":"159","author":"Sato","year":"2016","journal-title":"J. Biochem."},{"key":"10.1016\/j.expneurol.2022.114170_bb0415","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-444-63486-3.00003-7","article-title":"Neural ECM molecules in synaptic plasticity, learning, and memory","volume":"214","author":"Senkov","year":"2014","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2022.114170_bb0420","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fnmol.2017.00269","article-title":"Loss of FMRP impaired hippocampal long-term plasticity and spatial learning in rats","volume":"10","author":"Tian","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0425","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/sj.ijo.0800959","article-title":"Weight loss and changes in energy metabolism in massively obese adolescents","volume":"23","author":"Tounian","year":"1999","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.expneurol.2022.114170_bb0430","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2022.114170_bb0435","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1601-183X.2011.00763.x","article-title":"The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice","volume":"11","author":"Vinueza Veloz","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.expneurol.2022.114170_bb0440","doi-asserted-by":"crossref","first-page":"39944","DOI":"10.1074\/jbc.M205147200","article-title":"Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning","volume":"277","author":"Weeber","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2022.114170_bb0445","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1073\/pnas.94.10.5395","article-title":"Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation","volume":"94","author":"Weiler","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2022.114170_bb0450","article-title":"Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome","volume":"2012","author":"Winarni","year":"2012","journal-title":"Case Rep. Genet."},{"key":"10.1016\/j.expneurol.2022.114170_bb0455","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1073\/pnas.0700438104","article-title":"Structure of a receptor-binding fragment of reelin and mutational analysis reveal a recognition mechanism similar to endocytic receptors","volume":"104","author":"Yasui","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2022.114170_bb0460","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/npp.2017.177","article-title":"Effect of the mGluR5-NAM basimglurant on behavior in adolescents and adults with fragile X syndrome in a randomized, double-blind, placebo-controlled trial: FragXis phase 2 results","volume":"43","author":"Youssef","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2022.114170_bb0465","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nn1893","article-title":"A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability","volume":"10","author":"Zalfa","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114170_bb0470","doi-asserted-by":"crossref","first-page":"10468","DOI":"10.1038\/srep10468","article-title":"GABAB receptor upregulates fragile X mental retardation protein expression in neurons","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2022.114170_bb0475","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1440-1789.2010.01165.x","article-title":"Spatiotemporal expression of PSD-95 in Fmr1 knockout mice brain","volume":"31","author":"Zhu","year":"2011","journal-title":"Neuropathology"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622001959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622001959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:11:33Z","timestamp":1758003093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488622001959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":95,"alternative-id":["S0014488622001959"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114170","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114170"}}